1.
Mohsen Karimi, Christer Nilsson, Marios Dimitriou, Monika Jansson, Hans Matsson, Per Unneberg, Sören Lehmann, Juha Kere, Eva Hellström-Lindberg. High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia. Haematologica 2015;100(6):e223-e225; https://doi.org/10.3324/haematol.2014.118034.